MedPath

Epidural Nalbuphine for Postcesarean Epidural Morphine Induced Pruritus

Phase 4
Completed
Conditions
Cesarean Section
Interventions
Registration Number
NCT00707824
Lead Sponsor
Mahidol University
Brief Summary

Can epidural nalbuphine reduce incidence or severity of epidural morphine induced pruritus in patient undergoing cesarean section?

Detailed Description

182 parturients,ASA 1-2 undergoing cesarean section under epidural block were enrolled in the study. After obtaining informed consent,all received epidural anesthesia using 2% lidocaine with epinephrine 1:200000 via epidural cathetes at L2-3 or L3-4 in a volume suffient to achieve a T4 sensory level bilaterally.

After the umbilical cord was clamped,patients were assigned randomly to three groups.The placebo group,N-5 group,and N-10 group received 4 ml epidural solution containing morphine 4 mg plus either saline, nalbuphine 5 mg, and nalbuphine 10 mg respectively.At the post anesthetic care unit, intravenous pethidine PCA were administered for inadequate pain control.

Outcome measures :

Incidence and severity of postoperative pruritus Quality of pain control Side effects of epidural morphine and nalbuphine such as respiratory depression,sedation

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
165
Inclusion Criteria
  • full term parturient undergoing elective cesarean section
  • ASA 1-2
Exclusion Criteria
  • drug or alcohol abuses
  • contraindication for regional anesthesia
  • received opioids within 12 hours

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
1NSS1= placebo
2nalbuphine2=nalbuphine 5 mg
3nalbuphine3=nalbuphine 10 mg
Primary Outcome Measures
NameTimeMethod
incidence and severity of pruritus24 hr
Secondary Outcome Measures
NameTimeMethod
visual analogue pain score24 hr

Trial Locations

Locations (1)

Mahidol University

🇹🇭

Bangkoknoi, Bangkok, Thailand

© Copyright 2025. All Rights Reserved by MedPath